The accelerated approval of Modeyso for diffuse midline glioma with an H3 K27M mutation, is a step in the right direction but ...

Strong cash position of $12.1 million expected to fund operations into the second half of 2026Driving lead program, TPI 287, towards Phase 2 study for treatment of glioblastoma multiforme (GBM) ...

Strong cash position of $12.1 million expected to fund operations into the second half of 2026Driving lead program, TPI 287, towards Phase 2 study for treatment of glioblastoma multiforme (GBM) HOUSTO ...

Linda Scelza knew what would happen when she told her son, Ryder, it was “OK to go.” Ryder Scelza took two more breaths and then died in his her arms, she said. He was 21. Ryder Scelza, of Rocky Hill, ...

Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) ("Shuttle Pharma" or the "Company"), a discovery and development stage specialty pharmaceutical ...

Gliomas are a type of primary brain tumour originating from glial cells that support and protect nerve cells in the brain and spinal cord. Here's what to know.